Ken Anderson Basic and Translational Research Award
The Ken Anderson Basic and Translational Research Award was established by IMS to honor the seminal contributions of Professor Ken Anderson to bench to bedside translational research. This award is given to an investigator to recognize excellence in translational research in myeloma.
Recipient Profile
Noopur S. Raje, MD, is a professor of medicine at Harvard Medical School, the director of the Center for Multiple Myeloma, and the Rita Kelley Chair in Oncology at Massachusetts General Hospital Cancer Center in Boston, MA, USA. She studied medicine at B.J. Medical College, Pune University, India, and trained at Massachusetts General Hospital and at the Dana-Farber Cancer Institute, Boston.
Professor Raje’s research focuses primarily on developing novel therapeutic strategies for the treatment of multiple myeloma and related plasma cell disorders, which aims to identify cellular signaling pathways that contribute to the survival and proliferation of myeloma cells in the bone environment and design clinical trials to specifically harness these.
Professor Raje is co-chair of the National Cancer Institute Myeloma Steering Committee, a committee member of the International Myeloma Society, a member of the International Myeloma Working Group, and serves on the National Comprehensive Cancer Network Clinical Practice Guidelines Committee for Multiple Myeloma. She has received several awards, has published widely on multiple myeloma, and is an ad hoc reviewer for several journals including Blood, Clinical Cancer Research, Leukemia, and the American Journal of Hematology.
Past Recipients
- 2017 – I. Ghobrial
- 2019 – C. Mitsiades
- 2021 – E. P. Neri
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
